newsfilter
← Latest News
Business Wire·

SAB Biotherapeutics to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibody therapeutics, today announced that Eddie J. Sullivan, PhD, co-fo